Indapamide 2.5mg Tablet Franchise in Ahmedabad

Antihypertensive Diuretic Tablet Supplier in Bangalore

Indapamide Tablet Distributor in Hyderabad

Hypertension Management Tablet Franchise Opportunity in Jaipur

Cardiovascular Medicine Stockist in Mumbai
Indapamide Tablet Manufacturing & Export in Chandigarh

Home/Products /indapamide-2-5mg-tablet

Indatake 2.5 Tablet

Composition : Indapamide (2.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Indatake 2.5 Tablet contains Indapamide 2.5mg, a potent thiazide-like diuretic widely used for the treatment of hypertension and edema. It helps reduce fluid retention, lowers blood pressure, and supports cardiovascular health effectively in adult patients.

Indapamide acts on the renal tubules to promote sodium and water excretion, helping to control high blood pressure and relieve swelling associated with heart failure, renal impairment, or liver disease. Its consistent efficacy and safety make it a preferred choice in clinical practice.

For distributors, hospitals, and pharmacy suppliers, Indatake 2.5 Tablet is a high-demand cardiovascular product, regularly prescribed in outpatient departments, inpatient care, cardiology clinics, and general medical practice. Its steady prescription pattern ensures continuous market demand.

Adding Indatake 2.5 Tablet enhances your cardiovascular and antihypertensive segment, providing strong opportunities in hospital supply chains, pharmacy distribution, bulk institutional orders, export markets, and third-party manufacturing. Its clinical reliability and essential therapeutic role make it a profitable addition for pharmaceutical distributors.

Read More

About the Product

Indatake 2.5 Tablet contains Indapamide 2.5mg, a potent thiazide-like diuretic widely used for the treatment of hypertension and edema. It helps reduce fluid retention, lowers blood pressure, and supports cardiovascular health effectively in adult patients.

Indapamide acts on the renal tubules to promote sodium and water excretion, helping to control high blood pressure and relieve swelling associated with heart failure, renal impairment, or liver disease. Its consistent efficacy and safety make it a preferred choice in clinical practice.

For distributors, hospitals, and pharmacy suppliers, Indatake 2.5 Tablet is a high-demand cardiovascular product, regularly prescribed in outpatient departments, inpatient care, cardiology clinics, and general medical practice. Its steady prescription pattern ensures continuous market demand.

Adding Indatake 2.5 Tablet enhances your cardiovascular and antihypertensive segment, providing strong opportunities in hospital supply chains, pharmacy distribution, bulk institutional orders, export markets, and third-party manufacturing. Its clinical reliability and essential therapeutic role make it a profitable addition for pharmaceutical distributors.

Some patients may experience dizziness, headache, increased urination, muscle cramps, or electrolyte imbalance. Rarely, hypotension, hyperglycemia, or gout flare-ups may occur.

Indatake 2.5 Tablet is indicated for the management of hypertension, edema associated with congestive heart failure, and other fluid retention disorders, as prescribed by a healthcare professional.

Use under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolytes is recommended. Caution is advised in patients with kidney disease, diabetes, or gout.

Store Imafix 100 Capsule in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation